Literature DB >> 9003629

Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital.

M Gazouli1, M E Kaufmann, E Tzelepi, H Dimopoulou, O Paniara, L S Tzouvelekis.   

Abstract

During a 3-month period, six Klebsiella pneumoniae isolates resistant to cefoxitin and penicillin-inhibitor combinations were derived from patients in the intensive care unit of a hospital in Athens, Greece. Enterobacterial repetitive intergenic consensus PCR and pulsed-field gel electrophoresis provided evidence of the clonal origin of the isolates. Conventional techniques and ribotyping were inadequate in proving that the isolates were related. Resistance was due to a plasmidic class C beta-lactamase.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9003629      PMCID： PMC229613          DOI： 10.1128/jcm.35.2.508-510.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  ERIC sequences: a novel family of repetitive elements in the genomes of Escherichia coli, Salmonella typhimurium and other enterobacteria.

Authors:  C S Hulton; C F Higgins; P M Sharp
Journal:  Mol Microbiol       Date:  1991-04       Impact factor: 3.501

Review 2.  Molecular epidemiology: application of contemporary techniques to the typing of microorganisms.

Authors:  J N Maslow; M E Mulligan; R D Arbeit
Journal:  Clin Infect Dis       Date:  1993-08       Impact factor: 9.079

3.  On the incidence of antibiotic resistance among aerobic gram-negative rods isolated in Greek hospitals.

Authors:  N J Legakis; L S Tzouvelekis; A Tsakris; J N Legakis; A C Vatopoulos
Journal:  J Hosp Infect       Date:  1993-07       Impact factor: 3.926

4.  Klebsiella serotyping by counter-current immunoelectrophoresis.

Authors:  J M Palfreyman
Journal:  J Hyg (Lond)       Date:  1978-10

5.  Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae.

Authors:  J Garaizar; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

6.  Identification of a novel plasmid-mediated beta-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae.

Authors:  L S Tzouvelekis; E Tzelepi; A F Mentis; A Tsakris
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

7.  Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.

Authors:  A F Ehrhardt; C C Sanders; K S Thomson; C Watanakunakorn; I Trujillano-Martin
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

8.  Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital.

Authors:  E H Bingen; P Desjardins; G Arlet; F Bourgeois; P Mariani-Kurkdjian; N Y Lambert-Zechovsky; E Denamur; A Philippon; J Elion
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital.

Authors:  A Gouby; C Neuwirth; G Bourg; N Bouziges; M J Carles-Nurit; E Despaux; M Ramuz
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

10.  Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.

Authors:  G A Papanicolaou; A A Medeiros; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191
View more
  9 in total

1.  Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase in the premature intensive care unit of a Hungarian hospital.

Authors:  D Szabó; Z Filetóth; J Szentandrássy; M Némedi; E Tóth; C Jeney; G Kispál; F Rozgonyi
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece.

Authors:  E Lebessi; H Dellagrammaticas; P T Tassios; L S Tzouvelekis; S Ioannidou; M Foustoukou; N J Legakis
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Facilitated molecular typing of Shigella isolates using ERIC-PCR.

Authors:  Margaret Kosek; Pablo Peñataro Yori; Robert H Gilman; Henry Vela; Maribel Paredes Olortegui; Cesar Banda Chavez; Maritza Calderon; Juan Perez Bao; Eric Hall; Ryan Maves; Rosa Burga; Graciela Meza Sanchez
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

5.  Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa.

Authors:  S Y Essack; L M Hall; D G Pillay; M L McFadyen; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

6.  Characterization of a novel AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in China.

Authors:  Qian Wang; Jun Cheng; Yan Chen; Ying Ye; Jia-Bin Li; Xue-Jun Zhang
Journal:  Curr Microbiol       Date:  2008-09-10       Impact factor: 2.188

Review 7.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

8.  Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins.

Authors:  Monica Cartelle; Maria del Mar Tomas; Sonia Pertega; Alejandro Beceiro; M Angeles Dominguez; David Velasco; Francisca Molina; Rosa Villanueva; German Bou
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

9.  Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study.

Authors:  Paul Chabert; Judith Provoost; Sabine Cohen; Céline Dupieux-Chabert; Laurent Bitker; Tristan Ferry; Sylvain Goutelle; Jean-Christophe Richard
Journal:  Ann Intensive Care       Date:  2022-09-30       Impact factor: 10.318
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.